In this study, we suggested that VEGF staining scores, HIF-1α, HIF-2α, p53 positivity, MVD, and Ki-67 counts may be used for the prediction of prognosis in patients with ccRCC. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.